Evidence map›Paper›PMID 41727670›Full record

ArticleFrontiers in oncology2026

Machine learning model based on dual-layer detector spectral CT radiomics features for differentiating luminal and non-luminal breast cancer.

Zhijing Song, Yikun Ma, Zhiyang Dou, Bo Shi

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhijing SongAnhui Key Laboratory of Digital Medicine and Intelligent Health, School of Medical Imaging, Bengbu Medical University, Bengbu, China.
Yikun MaDepartment of Radiology, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Zhiyang DouAnhui Key Laboratory of Digital Medicine and Intelligent Health, School of Medical Imaging, Bengbu Medical University, Bengbu, China.
Bo ShiAnhui Key Laboratory of Digital Medicine and Intelligent Health, School of Medical Imaging, Bengbu Medical University, Bengbu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to explore the value of a machine learning (ML) model based on dual-layer detector spectral CT (DLCT) radiomic features in predicting Luminal versus non-Luminal breast cancer (BC). Methods: A retrospective analysis was conducted on 128 pathologically confirmed BC patients from the Department of Breast Surgery, Jiangsu Cancer Hospital. DLCT chest enhancement images were analyzed, with regions of interest delineated to extract radiomic features. Optimal features were selected through univariate analysis, correlation analysis, and LASSO algorithm, followed by ML model construction. Results: A total of 1,037 radiomic features were extracted, from which 13 optimal features were selected. Combined with clinical parameters (age, body mass index (BMI), and menopausal status), seven ML models were constructed. Among them, the Gaussian Naive Bayes (GNB) model demonstrated the best performance, achieving an area under the receiver operating characteristic curve (AUC) of 0.778 (95% CI: 0.582-0.974), accuracy of 0.821, sensitivity of 0.833, and specificity of 0.778, outperforming the other six models. Conclusions: The GNB model demonstrated relatively superior and stable predictive performance in internal testing, suggesting that DLCT radiomics may offer a potential auxiliary tool for distinguishing between Luminal and non-Luminal BC. However, further validation through large-scale multicenter studies is required.

Indexed as

breast cancerdual-layer detector spectral CTmachine learningmolecular subtyperadiomics

Identifiers

PMID41727670
PMCPMC12916351

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.